Saturday, 17 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

AVENIR TELECOM Stock Went Down By Over 34% In The Last 21 Sessions

Loading stream...

(vianews) - shares of avenir telecom (cac 40: avt.pa) slid by a staggering 34.98% in 21 sessions from €0.32 to €0.21 at 02:42 est on monday, after two consecutive sessions in a row of gains. cac 40 is jumping 0.45% to €7,414.85, after two consecutive sessions in a row of gains.

about avenir telecom

avenir telecom s.a. designs and distributes mobile phones and mobility accessories in europe, the middle east, africa, asia, oceania, and the americas. the company also provides chargers, cables, memory cards, and screen protectors. it offers its products under the energizer brand. the company was incorporated in 1989 and is headquartered in marseille, france.

earnings per share

as for profitability, avenir telecom has a trailing twelve months eps of €149.73.

volume

today's last reported volume for avenir telecom is 1672540 which is 66.68% below its average volume of 3712680.

more news about avenir telecom (avt.pa).

Categories

stockMarket

Tags

AVENIR TELECOMStock PricePrice DownAVT.PAMarket Session NowStock Price DownStock Market NowMarket SessionStock MarketStock
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com